A Fujifilm Biotechnologies’ commercial-scale cell culture manufacturing facility has been selected for the FDA’s PreCheck Pilot Program, the company announced. The CDMO’s Holly Springs, North Carolina, facility was selected as one of seven participants in the program designed to strengthen United States pharmaceutical manufacturing capabilities and accelerate patient access to critical medicines. “We are honored…
BD names new president of Pharmacy Automation biz
BD (NYSE:BDX) announced today that it appointed Matthew Sassone as worldwide president of its Pharmacy Automation business. Sassone now leads the global business within the BD Medication Management Solutions business unit. His appointment goes into effect immediately. In the role, Sassone’s responsibilities include driving global strategy, performance and growth for Pharmacy Automation as part of…
Pfannenberg introduces lifecycle safety system as F-Gas rules shift industrial and pharma refrigerants
As tighter European F-Gas rules and the rollout of lower-GWP refrigerants force changes in industrial chillers and process cooling, German thermal-management specialist Pfannenberg has introduced an engineering-led safety system. The new offering is intended to help facilities, including pharmaceutical processing sites, manage the refrigerant transition without compromising equipment safety or audit trails. The system, Pfannenberg…
Cardinal Health to build pharma distribution plant in Indianapolis
Cardinal Health (NYSE:CAH) today announced plans for a new flagship forward distribution center in Indianapolis. The new, state-of-the-art facility will further expand and modernize its national pharmaceutical distribution network. Dublin, Ohio-based Cardinal Health plans to include automation and the latest technology advancements in the new plant. It hopes to support the segment’s distribution of more…
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Nymi today announced a strategic partnership with Caliber Technologies to accelerate digital transformation in pharmaceutical manufacturing. The partnership aims to enable passwordless authentication on the shop floor. This reduces manual logins and streamlines electronic signatures. Nymi offers the Band biometric, wearable device that authenticates users via fingerprint and facilitates a secure, continuous identity across applications,…
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
Roche and its Genentech unit today announced plans to invest more than $700 million in a new manufacturing facility in the U.S. The company plans to build a new 700,000 square-foot, state-of-the-art drug manufacturing plant in Holly Springs, North Carolina. It expects to add more than 400 high-wage manufacturing jobs once operational, plus more than…
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
ICU Medical and Otsuka Pharmaceutical Factory (OPF) announced the formation of a new joint venture to strengthen supply chain resiliency. In this joint venture, the companies say they formed Otsuka ICU Medical LLC. It aims to strengthen IV solutions supply chains and drive innovation in the North American market. The need for a more resilient…
Nelipak earns certifications at Derry facility
Nelipak announced today that it received International Sustainability and Carbon Certification (ISCC) Plus for its Derry, Northern Ireland facility. ISCC PLUS is a globally recognized standard tracking recycled and bio-based materials through the supply chain. It verifies that companies meet environmental and social standards. Cranston, Rhode Island-based Nelipak manufactures healthcare packaging solutions and offers complementary…
Aragen brings in $100M to expand pharma outsourcing offerings
Aragen announced that it received a $100 million investment to support the expansion of its pharmaceutical outsourcing services. Quadria Capital, an Asian healthcare-focused private equity fund, made the investment. This results in the company acquiring a minority stake in Aragen, primarily through a fresh capital infusion. A small portion comes from the sale of shares…
WuXi to sell Irish vaccine site to Merck ahead of potential U.S. law limiting Chinese biotech business
Merck agreed to acquire a vaccine manufacturing facility in Ireland from WuXi, the Irish Foreign Direct Investment Arm (IDA) announced today. IDA Ireland said the move comes as part of long-term plans in Ireland for Merck Sharp & Dohme (MSD), Rahway, New Jersey–based Merck’s Ireland business. The acquisition of the facility, located in Dundalk, brings…









